| Pulmonary Embolism (PE) |
0.69 |
Significant (P = 0.001) |
31% lower risk of a life-threatening blood clot in the lungs. |
| All-Cause Mortality |
0.56 |
Significant (P < 0.001) |
44% lower risk of death from any cause during the study period. |
| Emergency Department (ED) Visits |
0.79 |
Significant (P < 0.001) |
21% fewer emergency room visits. |
| Venous Thromboembolism (VTE) |
0.83 |
Significant (P = 0.007) |
17% lower risk of blood clots forming in the deep veins. |
| Stroke / TIA ("Mini-Stroke") |
0.87 |
Significant (P = 0.039) |
13% lower risk of cerebrovascular events. |
| Myocardial Infarction (Heart Attack) |
0.86 |
Not Significant (P = 0.081) |
Trended toward lower risk, but not a definitive statistical difference. |
| Hospitalization |
0.96 |
Not Significant (P = 0.067) |
No meaningful statistical change in overnight hospital stays. |
| Coronary Revascularization |
1.03 |
Not Significant (P = 0.820) |
No difference in the need for heart surgeries or stents. |
Comments
Post a Comment